The Report Guru

According to research report the report Medical Power Supply Market is expected to reach USD 1,218.6 Million by 2022 from USD 885.3 Million in 2017, at a CAGR of 6.6% from 2017 to 2022. Factors such as growth in funding and infrastructure development, advancements in medical power supply products, and rising trend of home healthcare are driving the growth of the global medical power supply market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1208 Based on the current type, the medical power supply market is segmented into AC-DC power supply and DC-DC power supply. The AC-DC power supply segment is expected to account for the highest CAGR during the forecast period. The advantages of AC-DC over DC-DC power supply, such as low energy consumption, low risk of current leakage, and greater efficiency are supporting the growth of the AC-DC power supply market. The medical power supply market is segmented into power ranges of 200W and below, 201

The growth of this market is mainly driven by the growing geriatric population, increasing number of surgical procedures, and rising awareness programs globally. According to research report the surgical drains market is expected to reach USD 2.18 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 3.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206173813 • Based on application, the surgical drains market is segmented into general surgery, cardiac and thoracic surgery, orthopedic surgery, obstetrics/gynecology surgery, and other surgeries. The cardiac and thoracic surgery segment is expected to register the highest CAGR during the forecast period. • Based on product, the market is segmented into accessories and surgical drainage systems. The surgical drainage systems segment is expected grow at the highest CAGR during the forecast period. • Based on type, the surgical drains market is segmented into active drains and pas

Factors such as the growing industrial applications of hyperspectral imaging and increasing funding and investments are driving the growth of the global hyperspectral imaging systems market. According to research report the hyperspectral imaging systems market is projected to reach USD 25.2 billion by 2024 from USD 11.1 billion in 2019, at a CAGR of 17.8%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The players in this market include Headwall Photonics, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Corning Incorporated (US), Norsk Elektro Optikk AS (Norway), Resonon Inc. (US), Telops (Canada), Surface Optics Corporation (US), CytoViva, Inc. (US), Glana Sensors AB (Sweden), HyperMed Imaging, Inc. (US), inno-spec GmbH (Germany), Applied Spectral Imaging Ltd. (US), Raytheon Company (US), ChemImage Corporation (US), Cubert GmbH (Germany), BaySpec, Inc. (US), Camlin Ltd. (Ireland), Imec (Belgium), Brandywine Photonics (US), XIME

 According to research report thrombectomy devices market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 6.7% during the forecast period. This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, higher prevalence of thrombotic diseases among geriatric individuals, procedural benefits offered by mechanical thrombectomy in cardiac surgeries and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222966801 • On the basis of application, the thrombectomy devices market is segmented into cardiovascular, neurovascular, and peripheral vascular applications. Peripheral vascular segment is expected to be the fastest growing in the market during the forecast period. This growth can be attributed to the rising availability of medical reimbursements for peripheral throm

According to a new market research report Operating Room Integration Market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667 The growth in this market is driven by the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs. Also, emerging economies (such as China, India, Brazil, and Mexico) are expected to offer lucrative growth opportunities for market players during the forecast period. The general surgery segment accounted for the largest share of the operating room integration market, by application, in 2018. Factors such as the increasing incidence of breast cancer, colorectal cancer, liver cancer, GI disorders, and endocrine disorders as well as the rising number of general s

The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. According to research report the global genome editing market is projected to reach $6.28 billion by 2022 from $3.19 billion in 2017, at a CAGR of 14.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 •Based on technology, the genome editing market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to register the highest growth during the forecast period. •The global genome editing market, by application, is segmented into cell line engineering, genetic engineering, and other applications (diagno

According to research report the global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753 Growth in this market is mainly driven by the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases. On the basis of product, the global structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is expected to register the highest CAGR during the forecast period. The APAC region is projected to register the highest CAGR during the forecast period. Factors such as the rising geriatric population,

According to research report the global competent cells market is projected to reach $2.22 billion by 2022 from $1.37 billion in 2017, at a CAGR of 10.2%. Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 • By type, the chemically competent cells segment is expected to dominate the market in 2017 • By application, the cloning segment is expected to dominate the market in 2017 • By end user, the academic research institutes segment is expected to dominate the market in 2017 • North America to dominate the competent cells market in 2017 Product launches, acquisitions, and partnerships were some of the major strategies followed by key players in the competent cells market. These strategies were adopt

The report analyzes the Breast Cancer Liquid Biopsy Market by circulating biomarker, end user, and region. On the basis of circulating biomarkers, the market is segmented into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150106081 The factors driving the growth of this market are the increasing prevalence of cancer, increasing preference for non-invasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. According to the new market research report Breast Cancer Liquid Biopsy Market is expected to reach USD 411.1 million by 2022, at a CAGR of 23.1%. •Based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs)

In the last decade, the sternal closure systems market has witnessed several mergers and acquisitions. For instance, Vance Street Capital LLC and A&E Medical Corporation (US) acquired Medical Concepts (Netherlands), with the aim to increase their product portfolio of single-use medical products in 2016. In this report, the market has been segmented by product, procedure, material, and region. According to the new market research report Sternal Closure Systems Market is estimated to be valued at USD 2.02 billion in 2018 and is projected to reach USD 2.61 billion by 2023, at a CAGR of 5.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152164684 The factors driving the growth of this market are the technological advancements in sternotomy techniques, increasing target patient population coupled with the subsequent increase in the number of surgical procedures, and growing availability of medical reimbursements across major markets. •As

Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent According to research report the life science analytics market is projected to reach USD 33.2 billion by 2024 from USD 19.3 billion in 2019, at a CAGR of 11.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653 The life science analytics market has been segmented on the basis of type, component, application, delivery model, end user, and region. •Based on type, the life science analytics m

According to the new market research report the Spinal Implants and Surgery Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%. The advancements in spine surgeries technologies, such as the development of safer, more effective, advanced, simple, and easy-to-use spinal implants and devices; the increasing incidence of spinal disorders; and the launch of advanced bone grafting products are some of the key factors driving the growth of the Spinal Implants Devices Market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the Spinal Surgery Devices Market in 2019. Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and sp

The Asia Pacific region is expected to register the highest growth rate in the global eHealth market during the forecast period. Growing medical tourism, growing consumerism in the healthcare industry, accelerated economic growth of countries in the region, the implementation of new ICT guidelines, and the implementation of eHealth programs are the factors propelling the growth of the market in this region. According to the new market research report eHealth Market is expected to reach $132.35 Billion by 2023 from $47.60 Billion in 2018, at a CAGR of 22.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 The eHealth market in this report is segmented on the basis of product & service and end user. This report also provides market information on major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. • By type of eHealth solutions, the chronic care management apps are expected to

Factors such as the rising government funding in precision medicine initiatives, partnerships among pharmaceutical and software companies, the entry of new players & VC funding, and growth in the number of cancer patients are driving the growth of the precision medicine software market . Also, emerging markets, cloud-based solutions, and artificial intelligence in precision medicine may act as an important boosting factor for the exponential growth of the precision medicine software market. According to research report the precision medicine software market is projected to reach $2.0 billion by 2024 from $1.2 billion in 2019, at a CAGR of 11.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247980900 2bPrecise has a strong foothold in the precision medicine software market. The company caters to the healthcare technology and precision medicine needs of its global customers. 2bPrecise focuses on agreements and collaborations to expand i

Oral Care Market According to the new market research report the Oral Care Market is projected to reach USD 53.3 billion by 2025 from USD 45.8 billion in 2020, at a CAGR of 3.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80546246 The Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the Oral Care Market. Increasing the online purchase of oral care products is expected to create new growth opportunities for players operating in this market. The toothpaste segment is expected to account for the largest share of the Oral Hygiene Market in 2019. Based on product, the market is categorized into toothpaste, toothbrushes & accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions. In 2019, the toothpaste segment was expected to acc

According to the new market research report the Veterinary Reference Laboratory Market is projected to reach USD 5.6 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 10.5%. The Factors such as growth in the companion animal population, rising demand for pet insurance, an increasing number of veterinary practitioners in developed economies, increasing demand for animal-derived food products, and increasing incidence of transboundary and zoonotic diseases are driving the growth of this market during the forecast period. However, rising pet care costs and the increasing demand for POC testing and portable instruments are restraining the growth of this market to some extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256972714 The Veterinary Reference Laboratories Market is segmented based on the type of service, application, animal, and region. Due to lockdown restrictions and social distancing protocols due to COVID-19 across va

Medical device contract manufacturers specialize in a certain process or task and offer expertise from the frequent practice of their manufacturing. Service or services for customers, clients, and inventors of medical devices include product concept and development, process validation and verification, production, or highly specialized manufacturing, and packaging. Medical device contract manufacturing is the system by which a manufacturing company makes medical devices or components of medical devices that can be later sold by another company. According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 Jabil Inc. (US

Artificial Tendons and Ligaments Market The growth of this market is primarily driven by factors such as the increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics. According to research report Artificial Tendons and Ligaments Market is expected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6% Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176955103 The artificial tendons and ligaments market is segmented on the basis of application and region. Based on application, the market is segmented into knee injuries, shoulder injuries, foot and ankle injuries, and other injuries (spine and hip injuries). Kn

Growth in the clinical alarm management market can be attributed to the increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-containment in healthcare delivery, and rising prominence and usage of big data and mHealth tools. According to research report the clinical alarm management market is expected to reach $1,724 million by 2023 from an estimated $457 million in 2018, at a CAGR of 30.4% during the forecast period. Download PDF Brchure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577 The major clinical alarm management vendors include Koninklijke Philips (Netherlands), Vocera Communications (US), Ascom Holdings (Switzerland), Spok, Inc. (US), Bernoulli Enterprise (US), Connexall (Canada), Mobile Heartbeat (US), GE Healthcare (US), Capsule Technologie (US), and Masimo Corporation (US). These players have adopted various growth strategies, such as product launches and enhancements; acquisitions;

The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market. According to the new market research report Immunoassay Market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The immunoassays market is consolidated in nature due to the presence of a large number of players. Key players in the market include Abbott Laboratories (US), Roche (Switzerland), Siemens (Germany), Danaher Corporation (US), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Thermo Fisher Scientific (US), QIAGEN (Netherlands), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Merck (Germany), Agilent Technologies (US), Quidel Corporatio

A pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally. When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias. A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias. According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 • The MRI compatible pacemakers segment, by type, is projected to grow at the highest CAGR during the forecast period. The development of MRI Compatible pacemakers is a major advancement in the pacemakers market. It is estimated that 75% of patients who currently have an implantable cardiac pacemaker will need MRI scans during their lifetimes. • The